|
π
|
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
13 auth.
Laura M. Spring,
G. Fell,
A. Arfè,
C. Sharma,
R. Greenup,
K. Reynolds,
Barbara L. Smith,
B. Alexander,
B. Moy,
S. Isakoff,
...
G. Parmigiani,
L. Trippa,
A. Bardia
|
8 |
2020 |
8
π
|
|
π
|
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
31 auth.
T. Bevers,
M. Helvie,
E. Bonaccio,
K. Calhoun,
M. Daly,
W. Farrar,
J. Garber,
R. Gray,
C. Greenberg,
R. Greenup,
N. Hansen,
Randall Harris,
A. Heerdt,
T. Helsten,
L. Hodgkiss,
...
Tamarya L. Hoyt,
John G. Huff,
L. Jacobs,
C. Lehman,
B. Monsees,
B. Niell,
Catherine C. Parker,
M. Pearlman,
L. Philpotts,
L. B. Shepardson,
M. Smith,
M. Stein,
Lusine Tumyan,
Cheryl Williams,
Mary Anne Bergman,
Rashmi Kumar
|
8 |
2018 |
8
π
|
|
π
|
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
26 auth.
M. Whitley,
Diana M. Cardona,
Alexander L. Lazarides,
I. SpasojeviΔ,
J. Ferrer,
J. Cahill,
Chang-Lung Lee,
M. Snuderl,
D. Blazer,
E. Hwang,
R. Greenup,
P. Mosca,
Jeffrey K. Mito,
K. Cuneo,
N. Larrier,
...
Erin K O'Reilly,
R. Riedel,
W. Eward,
D. Strasfeld,
D. Fukumura,
R. Jain,
W. D. Lee,
L. Griffith,
M. Bawendi,
D. Kirsch,
B. Brigman
|
7 |
2016 |
7
π
|
|
π
|
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
7 auth.
M. Worni,
I. Akushevich,
R. Greenup,
D. Sarma,
M. Ryser,
E. Myers,
...
E. Hwang
|
7 |
2015 |
7
π
|
|
π
|
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
19 auth.
O. Fayanju,
O. Fayanju,
Yi Ren,
Samantha M. Thomas,
Samantha M. Thomas,
R. Greenup,
R. Greenup,
J. Plichta,
J. Plichta,
L. Rosenberger,
...
L. Rosenberger,
N. Tamirisa,
Jeremy Force,
Jeremy Force,
J. Boughey,
Terry Hyslop,
Terry Hyslop,
E. S. Hwang,
E. S. Hwang
|
7 |
2018 |
7
π
|
|
π
|
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
19 auth.
O. Fayanju,
O. Fayanju,
Yi Ren,
Samantha M. Thomas,
Samantha M. Thomas,
R. Greenup,
R. Greenup,
J. Plichta,
J. Plichta,
L. Rosenberger,
...
L. Rosenberger,
N. Tamirisa,
Jeremy Force,
Jeremy Force,
J. Boughey,
Terry Hyslop,
Terry Hyslop,
E. S. Hwang,
E. S. Hwang
|
7 |
2018 |
7
π
|
|
π
|
Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study
11 auth.
J. Jakub,
A. Peled,
R. Gray,
R. Greenup,
J. Kiluk,
V. Sacchini,
...
S. Mclaughlin,
J. Tchou,
R. Vierkant,
A. Degnim,
S. Willey
|
7 |
2017 |
7
π
|
|
π
|
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach
14 auth.
Grace L. Smith,
Matthew P. Banegas,
C. Acquati,
Shine Chang,
F. Chino,
R. Conti,
R. Greenup,
Juliet L Kroll,
M. Liang,
M. Pisu,
...
K. Primm,
Michael Roth,
V. Shankaran,
K. R. Yabroff
|
7 |
2022 |
7
π
|
|
π¬
|
Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge.
M. Bahl,
J. Baker,
R. Greenup,
S. Ghate
|
7 |
2015 |
7
π¬
|
|
π¬
|
Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI?
M. Bahl,
J. Baker,
R. Greenup,
S. Ghate
|
7 |
2015 |
7
π¬
|
|
π¬
|
Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
S. Hanson,
R. Punzalan,
R. Greenup,
Hua Liu,
Thomas T. Sato,
P. Havens
|
6 |
2010 |
6
π¬
|
